Unicycive Therapeutics (UNCY) Current Leases (2021 - 2026)
Unicycive Therapeutics posted quarterly Current Leases of $598000.0 for Q1 2026, up 9.12% year-on-year from $548000.0 in Q1 2025, and up 411.11% on a QoQ basis from $117000.0 in Q4 2025.
Unicycive Therapeutics (UNCY) has 6 years of Current Leases data on file, last reported at $598000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 9.12% year-over-year to $598000.0; the trailing twelve-month figure through Mar 2026 stood at $598000.0 (up 9.12% YoY), and the FY2025 full-year result was $117000.0, down 79.26% from the prior year.
- Current Leases for Q1 2026 stood at $598000.0, up from $117000.0 in the prior quarter.
- Across five years, Current Leases topped out at $598000.0 in Q1 2026 and bottomed at $117000.0 in Q4 2025.
- The 5-year median for Current Leases is $314000.0 (2023), against an average of $329470.6.
- The widest annual swing landed in 2023, when Current Leases jumped 110.97%; it then tumbled 79.26% in 2025.
- A 5-year view of Current Leases shows it stood at $155000.0 in 2022, then surged by 110.97% to $327000.0 in 2023, then soared by 72.48% to $564000.0 in 2024, then slumped by 79.26% to $117000.0 in 2025, then jumped by 411.11% to $598000.0 in 2026.
- The last three Current Leases figures came in at $598000.0 (Q1 2026), $117000.0 (Q4 2025), and $265000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Unicycive Therapeutics | 181.94 Mn | 127.36 Mn | - | 598,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 598,000.00 |
| Dec 31, 2025 | 117,000.00 |
| Sep 30, 2025 | 265,000.00 |
| Jun 30, 2025 | 409,000.00 |
| Mar 31, 2025 | 548,000.00 |
| Dec 31, 2024 | 564,000.00 |
| Sep 30, 2024 | 542,000.00 |
| Jun 30, 2024 | 360,000.00 |
| Mar 31, 2024 | 343,000.00 |
| Dec 31, 2023 | 327,000.00 |
| Sep 30, 2023 | 314,000.00 |
| Jun 30, 2023 | 303,000.00 |
| Mar 31, 2023 | 276,000.00 |
| Dec 31, 2022 | 155,000.00 |
| Sep 30, 2022 | 165,000.00 |
| Jun 30, 2022 | 160,000.00 |
| Mar 31, 2022 | 155,000.00 |
| Dec 31, 2021 | 151,000.00 |